Prof Grant McArthur
The Lorenzo Galli Chair in Melanoma & Skin Cancers
Melbourne Medical School
655 Scholarly works
40 Projects
HIGHLIGHTS
2026
Research grants (ARC, NHMRC, MRFF)
Improving Outcomes for Patients With Melanoma
2023
Journal article
Designing a wholly online, multidisciplinary Master of Cancer Sciences degree
DOI: 10.1186/s12909-023-04537-12020
Research Grant
ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients
2017
Research grants (other domestic)
Novel Approaches for Overcoming Resistance to Therapies for Advanced Melanoma
2014
Journal article
Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: A virtual appliance approach for instant deployment
DOI: 10.1371/journal.pone.00952172014
Journal article
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
DOI: 10.1158/2159-8290.CD-13-04402013
Journal article
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours
DOI: 10.1038/srep03494
RECENT SCHOLARLY WORKS
2026
Journal article
A Framework for MRI Characterization of Intracranial Metastatic Disease
DOI: 10.1148/rycan.2506272026
Journal article
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse features
DOI: 10.1016/j.jaad.2025.10.0362026
Journal article
Current and emerging opportunities for deintensification of systemic therapies in melanoma: A scoping review
DOI: 10.1016/j.ejca.2025.1161322025
Journal article
Patterns of recurrence after lymphadenectomy for melanoma lymph node metastasis at high risk of recurrence in the modern era of adjuvant systemic therapy.
DOI: 10.1016/j.ejso.2025.1111352025
Journal article
Multimodal AI and tumour microenvironment integration predicts metastasis in cutaneous melanoma
DOI: 10.1038/s41467-025-65051-02025
Other
Supplementary Data DS1 from A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
DOI: 10.1158/1078-0432.307075642025
Journal article
IMG-24. Improving the MRI characterization of intracranial metastatic disease: a critical need
DOI: 10.1093/neuonc/noaf201.11032025
Journal article
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8 T cell immunity against melanoma
DOI: 10.1016/j.immuni.2025.10.004